Your browser doesn't support javascript.
loading
Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis.
Boeddha, Navin P; Driessen, Gertjan J; Hagedoorn, Nienke N; Kohlfuerst, Daniela S; Hoggart, Clive J; van Rijswijk, Angelique L; Ekinci, Ebru; Priem, Debby; Schlapbach, Luregn J; Herberg, Jethro A; de Groot, Ronald; Anderson, Suzanne T; Fink, Colin G; Carrol, Enitan D; van der Flier, Michiel; Martinón-Torres, Federico; Levin, Michael; Leebeek, Frank W; Zenz, Werner; de Maat, Moniek P M; Hazelzet, Jan A; Emonts, Marieke; Dik, Willem A.
Afiliação
  • Boeddha NP; Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Driessen GJ; Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Hagedoorn NN; Department of Paediatrics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Kohlfuerst DS; Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Hoggart CJ; Department of General Paediatrics, Medical University of Graz, Graz, Austria.
  • van Rijswijk AL; Section of Pediatrics, Imperial College London, London, United Kingdom.
  • Ekinci E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY.
  • Priem D; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Schlapbach LJ; Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Herberg JA; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • de Groot R; Child Health Research Center, The University of Queensland, Brisbane, QLD, Australia.
  • Anderson ST; Queensland Children`s Hospital, Brisbane, QLD, Australia.
  • Fink CG; Pediatric and Neonatal Intensive Care Unit, University Children's Hospital Zurich, Zurich, Switzerland.
  • Carrol ED; Section of Pediatrics, Imperial College London, London, United Kingdom.
  • van der Flier M; Radboudumc Technology Center Clinical Studies, Radboudumc, Nijmegen, The Netherlands.
  • Martinón-Torres F; Section of Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
  • Levin M; Radboud Center for Infectious Diseases, Radboudumc, Nijmegen, The Netherlands.
  • Leebeek FW; MRC Unit The Gambia at the LSHTM, Banjul, The Gambia.
  • Zenz W; Micropathology Ltd, University of Warwick Science Park, Venture Centre, Coventry, United Kingdom.
  • de Maat MPM; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Hazelzet JA; Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, UMC Utrecht, Utrecht, The Netherlands.
  • Emonts M; Paediatric Infectious Diseases and Immunology, Radboudumc, Nijmegen, The Netherlands.
  • Dik WA; Translational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Crit Care Explor ; 3(11): e0569, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34765980
ABSTRACT
IMPORTANCE A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 is hypothesized to play a role in the pathogenesis of invasive infection, but studies in sepsis are lacking.

OBJECTIVES:

To study A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 protein level in pediatric sepsis and to study the association with outcome.

DESIGN:

Data from two prospective cohort studies. SETTING AND

PARTICIPANTS:

Cohort 1 is from a single-center study involving children admitted to PICU with meningococcal sepsis (samples obtained at three time points). Cohort 2 includes patients from a multicenter study involving children admitted to the hospital with invasive bacterial infections of differing etiologies (samples obtained within 48 hr after hospital admission). MAIN OUTCOMES AND

MEASURES:

Primary outcome measure was mortality. Secondary outcome measures were PICU-free days at day 28 and hospital length of stay.

RESULTS:

In cohort 1 (n = 59), nonsurvivors more frequently had A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels above the detection limit than survivors at admission to PICU (8/11 [73%] and 6/23 [26%], respectively; p = 0.02) and at t = 24 hours (2/3 [67%] and 3/37 [8%], respectively; p = 0.04). In cohort 2 (n = 240), A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels in patients within 48 hours after hospital admission were more frequently above the detection limit than in healthy controls (110/240 [46%] and 14/64 [22%], respectively; p = 0.001). Nonsurvivors more often had detectable A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 levels than survivors (16/21 [76%] and 94/219 [43%], respectively; p = 0.003), which was mostly attributable to patients with Neisseria meningitidis. CONCLUSIONS AND RELEVANCE In children with bacterial infection, detection of A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 within 48 hours after hospital admission is associated with death, particularly in meningococcal sepsis. Future studies should confirm the prognostic value of A Disintegrin and Metalloproteinase with Thrombospondin Motifs-1 and should study pathophysiologic mechanisms.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article